STAT3 and breast carcinoma: One such compound, STA‐21, a naturally occurring deoxytetrangomycin, selectively binds to the SH2 domain, preventing STAT3 dimerization and nuclear translocation, thereby significantly reducing the proliferation and progression of breast cancer cells [260].